Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

BASF focuses on dolastatin derivatives

Feb. 17, 1997

Novel anti-HIV compounds disclosed by Novartis

Feb. 17, 1997

TK signal transduction modulators claimed by Sugen

Feb. 17, 1997

TK inhibitors disclosed by RCT

Feb. 14, 1997

BASF prepares dolastatin derivatives

Feb. 14, 1997

Zeneca describes ET antagonists

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...